Moderated by Gil Bashe, Managing Partner, Global Health, Finn Partners, hear from Junaid Bajwa, Chief Medical Scientist, Microsoft Research, Sheri McCoy, Board of Directors AstraZeneca, Chair of the Board, Certara, Michael Rosenblatt, MD, Chief Medical Officer, Flagship Pioneering, and Mel Spigelman, CEO, TB Alliance and the 2020 U.S. Prix Galien Best Pharmaceutical Product winner for Pretomanid.
With: Theodore Search, Pharm.D., Chief Executive Officer, Skipta - Informa Pharma Intelligence; Rachele Berria, Vice President and Medical Head, US Biopharmaceuticals AstraZeneca; Jessica Federer, Chief Executive Officer, US Huma; George Mathew, MD, Chief Medical Officer, North America DXC Technology; Nagaraja Srivatsan, Senior Vice President, Chief Digital Officer, Research and Development Solutions, IQVIA
With: Dr. Margaret “Peggy” Hamburg, former Commissioner of the U.S. Food and Drug Administration, Dr. Eric Rubin, Editor-in-Chief of the New England Journal of Medicine and Dr. Michelle Williams, Dean of the Faculty of the Harvard T.H. Chan School of Public Health. Moderated by: Dr. Max Gomez, Senior Medical Correspondent, CBS2 New York
Presented by The Jerusalem Ethics Forum and The Cura Foundation. Featuring a discussion with Michael Rosenblatt, MD, Chief Medical Officer of Flagship Pioneering and Tal Zaks, MD, PhD, Chief Medical Officer of Moderna Therapeutics. With an introduction by Dr. Robin Smith, President of The Cura Foundation.
How do we approach expediting the regulatory process while ensuring safety in times of a pandemic. Four incredible regulatory experts will discuss topics importance speed vs safety, sharing of data, importance of open label and real world evidence in times of crisis, supply restrictions due to demand over supply, and much more.